LAUSR

Key Points Question Among individuals with cancer, are members of racial and ethnic minority groups and those residing in socioeconomically disadvantaged areas more likely to experience cancer treatment delays and discontinuation after SARS-CoV-2 infection relative to non-Hispanic White individuals and those residing in areas of higher socioeconomic status? Findings In this cohort study of 4768 patients with cancer, non-Hispanic Black and Hispanic individuals were more likely to have cancer treatment delays of at least 14 days or treatment discontinuation relative to non-Hispanic White individuals; there was evidence of associations between area-level social determinants of health with cancer treatment delay or discontinuation. Meaning These findings suggest that COVID-19–related cancer treatment delays among vulnerable populations might contribute to worsening cancer survival inequities in the future.